These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18754097)

  • 1. [Cellular mechanisms of tumor response: clinical demands].
    Ganten MK; Weber MA; Ganten TM
    Radiologe; 2008 Sep; 48(9):820-31. PubMed ID: 18754097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oncological imaging for therapy response assessment].
    Stattaus J
    Radiologe; 2014 Jan; 54(1):69-78; quiz 79-80. PubMed ID: 24326357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response criteria in oncologic imaging: review of traditional and new criteria.
    Tirkes T; Hollar MA; Tann M; Kohli MD; Akisik F; Sandrasegaran K
    Radiographics; 2013; 33(5):1323-41. PubMed ID: 24025927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.
    Höink AJ; Heindel W; Buerke B
    Rofo; 2014 Oct; 186(10):927-36. PubMed ID: 25122173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Criteria for radiological assessment of therapy response: criteria-based appraisal].
    D'Anastasi M; Schramm NA; Reiser MF; Graser A
    Radiologe; 2013 Apr; 53(4):322-8. PubMed ID: 23553412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Imaging in oncology: terms and definitions].
    Brader P; Menu Y; Kreuzer S; Polanec S; Mayerhoefer M; Herold CJ
    Radiologe; 2013 Apr; 53(4):303-12. PubMed ID: 23536031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0.
    Chalian H; Töre HG; Horowitz JM; Salem R; Miller FH; Yaghmai V
    Radiographics; 2011; 31(7):2093-105. PubMed ID: 22084190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis.
    Kim HD; Kim BJ; Kim HS; Kim JH
    Korean J Intern Med; 2019 May; 34(3):608-617. PubMed ID: 29334722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Response Assessment for Precision Cancer Therapy: Response Evaluation Criteria in Solid Tumors and Beyond.
    Nishino M
    Am Soc Clin Oncol Educ Book; 2018 May; 38():1019-1029. PubMed ID: 30231378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pearls and pitfalls of response evaluation criteria in solid tumors (RECIST) v1.1 non-target lesion assessment.
    Morse B; Jeong D; Ihnat G; Silva AC
    Abdom Radiol (NY); 2019 Feb; 44(2):766-774. PubMed ID: 30196362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Quantitative Imaging for Predicting Response to Therapy: Techniques and Clinical Applications.
    Bera K; Velcheti V; Madabhushi A
    Am Soc Clin Oncol Educ Book; 2018 May; 38(38):1008-1018. PubMed ID: 30231314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Response criteria for malignant lymphoma].
    Ganten MK
    Radiologe; 2012 Apr; 52(4):330-7. PubMed ID: 22418972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [RECIST and the radiologist].
    Cervera Deval J
    Radiologia; 2014; 56(3):193-205. PubMed ID: 22902252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Imaging in Immunotherapy.
    Eleneen Y; Colen RR
    Adv Exp Med Biol; 2017; 995():141-153. PubMed ID: 28321816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT.
    Plathow C; Klopp M; Thieke C; Herth F; Thomas A; Schmaehl A; Zuna I; Kauczor HU
    Eur Radiol; 2008 Aug; 18(8):1635-43. PubMed ID: 18369634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors.
    Yanagawa M; Tatsumi M; Miyata H; Morii E; Tomiyama N; Watabe T; Isohashi K; Kato H; Shimosegawa E; Yamasaki M; Mori M; Doki Y; Hatazawa J
    J Nucl Med; 2012 Jun; 53(6):872-80. PubMed ID: 22582049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiological monitoring of the treatment of solid tumors in practice.
    Ganten MK; Ganten TM; Schlemmer HP
    Rofo; 2014 May; 186(5):466-73. PubMed ID: 24563412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern magnetic resonance procedures for assessing tumor response].
    Persigehl T; Heindel W; Bremer C
    Radiologe; 2008 Sep; 48(9):863-70. PubMed ID: 18696035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives.
    Marcus CD; Ladam-Marcus V; Cucu C; Bouché O; Lucas L; Hoeffel C
    Crit Rev Oncol Hematol; 2009 Dec; 72(3):217-38. PubMed ID: 18760935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.